Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

被引:491
作者
Briggs, Andrew H. [1 ]
Weinstein, Milton C. [2 ]
Fenwick, Elisabeth A. L. [1 ]
Karnon, Jonathan [3 ]
Sculpher, Mark J. [4 ]
Paltiel, A. David [5 ,6 ]
机构
[1] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow G12 8RZ, Lanark, Scotland
[2] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[3] Univ Adelaide, Sch Populat Hlth & Clin Practice, Adelaide, SA 5005, Australia
[4] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[5] Yale Univ, Sch Med, New Haven, CT USA
[6] Yale Univ, Sch Management, New Haven, CT USA
关键词
best practices; heterogeneity; sensitivity analysis; uncertainty analysis; value of information; NATURAL-HISTORY MODEL; COST-EFFECTIVENESS; ECONOMIC-EVALUATION; STRUCTURAL UNCERTAINTY; CALIBRATING MODELS; EXPECTED VALUE; INFORMATION; FRAMEWORK;
D O I
10.1016/j.jval.2012.04.014
中图分类号
F [经济];
学科分类号
02 ;
摘要
A model's purpose is to inform medical decisions and health care resource allocation. Modelers employ quantitative methods to structure the clinical, epidemiological, and economic evidence base and gain qualitative insight to assist decision makers in making better decisions. From a policy perspective, the value of a model-based analysis lies not simply in its ability to generate a precise point estimate for a specific outcome but also in the systematic examination and responsible reporting of uncertainty surrounding this outcome and the ultimate decision being addressed. Different concepts relating to uncertainty in decision modeling are explored. Stochastic (first-order) uncertainty is distinguished from both parameter (second-order) uncertainty and from heterogeneity, with structural uncertainty relating to the model itself forming another level of uncertainty to consider. The article argues that the estimation of point estimates and uncertainty in parameters is part of a single process and explores the link between parameter uncertainty through to decision uncertainty and the relationship to value of information analysis. The article also makes extensive recommendations around the reporting of uncertainty, in terms of both deterministic sensitivity analysis techniques and probabilistic methods. Expected value of perfect information is argued to be the most appropriate presentational technique, alongside cost-effectiveness acceptability curves, for representing decision uncertainty from probabilistic analysis.
引用
收藏
页码:835 / 842
页数:8
相关论文
共 32 条
[1]   Expected value of sample information calculations in medical decision modeling [J].
Ades, AE ;
Lu, G ;
Claxton, K .
MEDICAL DECISION MAKING, 2004, 24 (02) :207-227
[2]   Markov chain Monte Carlo estimation of a multiparameter decision model: Consistency of evidence and the accurate assessment of uncertainty [J].
Ades, AE ;
Cliffe, S .
MEDICAL DECISION MAKING, 2002, 22 (04) :359-371
[3]  
[Anonymous], GUID METH TECHN APPR
[4]  
[Anonymous], 2006, Decision modelling for health economic evaluation
[5]   Characterizing Structural Uncertainty in Decision Analytic Models: A Review and Application of Methods [J].
Bojke, Laura ;
Claxton, Karl ;
Sculpher, Mark ;
Palmer, Stephen .
VALUE IN HEALTH, 2009, 12 (05) :739-749
[6]   Calculating partial expected value of perfect information via Monte Carlo sampling algorithms [J].
Brennan, Alan ;
Kharroubi, Samer ;
O'Hagan, Anthony ;
Chilcott, Jim .
MEDICAL DECISION MAKING, 2007, 27 (04) :448-470
[7]  
Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.0.CO
[8]  
2-O
[9]   UNCERTAINTY IN THE ECONOMIC-EVALUATION OF HEALTH-CARE TECHNOLOGIES - THE ROLE OF SENSITIVITY ANALYSIS [J].
BRIGGS, A ;
SCULPHER, M ;
BUXTON, M .
HEALTH ECONOMICS, 1994, 3 (02) :95-104
[10]   Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs [J].
Brisson, M. ;
Edmunds, W. J. .
MEDICAL DECISION MAKING, 2006, 26 (05) :434-446